VC Funds Starting with P

PeakSpan Capital, founded in 2015, is a growth-stage venture capital firm focused on scaling business-to-business (B2B) software companies. Based in New York and San Mateo, PeakSpan operates with the mission of being a partner of choice for companies looking to grow from $3-5 million in annual recurring revenue (ARR) to $30 million or more. Specializing in industries like SaaS, analytics, marketing technology, and enterprise applications, the firm supports its portfolio with a hands-on, data-driven approach to help businesses scale efficiently. The firm’s investment strategy centers on leading rounds with initial check sizes typically ranging from $7-15 million. They look for companies that exhibit strong product-market fit and capital-efficient growth, typically targeting businesses that haven't raised significant institutional capital yet. With a $567 million third fund, PeakSpan has backed a number of successful B2B software firms, such as Cognism, Vyond, and Ecwid. PeakSpan's value-driven approach includes leveraging their proprietary technology stack and an extensive network of advisors to help companies navigate complex growth challenges. Co-founded by Matt Melymuka, PeakSpan prides itself on providing more than just capital, offering tailored guidance and strategic insights designed to deliver sustainable, risk-adjusted returns while preserving flexibility for founders. This focus on alignment with founders and their long-term goals has helped the firm develop a strong reputation in the growth equity space.

Pear VC (formerly Pejman Mar Ventures) is one of Silicon Valley's most respected pre-seed and seed specialist venture firms, founded in August 2013 by Pejman Nozad and Mar Hershenson and rebranded from Pejman Mar to Pear VC in August 2016 with the launch of its $75 million Fund II. Headquartered in Menlo Park, California, the firm leads rounds and has scaled its fund platform from a $50 million first fund to $160 million (Fund III) and an oversubscribed $432 million Fund IV closed in 2023, bringing cumulative capital raised to roughly $700 million. The 25-person team includes Founding Managing Partners Pejman Nozad and Mar Hershenson and Partner Kathleen Estreich. Pear operates an explicit three-stage framework covering pre-seed through Series A and has built distinctive sourcing programs including PearX, Pear Pre-Seed Ready, and an Emerging Managers in Residence program launched in September 2024. Across 263 investments Pear has seeded three public companies: DoorDash, Guardant Health, and Senti Biosciences. Additional billion-dollar breakouts from the portfolio include Gusto, Branch, Aurora Solar, and Vanta. In 2025 the firm made 34 new investments, with seven more in the first quarter of 2026. The firm has recorded 27 portfolio exits to date, including BioAge Labs and Voyage AI. The most recent liquidity event was the exit of Breakout Audio in May 2025. Pear VC combines high-frequency seed deployment with deep programmatic engagement, running accelerator-style programs that give the firm proprietary access to emerging founders before they reach the market. The result is a sourcing advantage built over a decade of community investment in Stanford, MIT, and the broader Silicon Valley founder ecosystem.

Pebblebed is an early-stage venture capital firm founded in 2022, based in San Francisco, California. The firm focuses on investing in technology companies that demonstrate profound technical insight and have the potential to build long-term competitive advantages. Pebblebed targets investments in companies that create significant value through innovation, aiming to support startups that are capable of developing strong market positions and enduring customer relationships. Pebblebed is particularly interested in businesses that can establish deep end-user stickiness, build strong brand loyalty, or create high switching costs for customers, thereby ensuring sustainable growth and market leadership. The firm’s investment strategy is characterized by its emphasis on deep technical knowledge, leveraging the expertise of its partners who have extensive backgrounds in engineering and technology. The firm has made several investments across various sectors, including AI, computing infrastructure, and other tech-driven industries. Pebblebed’s approach is to provide more than just capital; it aims to be a strategic partner to its portfolio companies, offering guidance and resources to help them scale and succeed in competitive markets.

Pegasus Tech Ventures, based in Silicon Valley, is a global venture capital firm managing over $2 billion in assets. Founded in 2011, Pegasus offers a unique Venture Capital-as-a-Service (VCaaS) model, partnering with large corporations to invest in emerging tech startups. This involves vetting investment opportunities, managing investments, and connecting startups to a network of over 30 international corporate partners to accelerate growth. Notable investments include high-profile companies such as SpaceX, Twitter, Airbnb, SoFi, DoorDash, and 23andMe. Pegasus' diverse portfolio spans sectors like consumer electronics, automotive, healthcare, AI, and fintech, reflecting its broad investment strategy. Recently, Pegasus launched a $100 million fund with Denka Company Limited, focusing on ICT, energy, healthcare, and sustainable living. This fund aims to invest in startups across the US, Europe, Israel, and Asia, enhancing Denka's growth and innovation efforts. Additionally, Pegasus founded and sponsors the Startup World Cup, one of the largest startup competitions globally, with a $1 million investment prize. This competition supports regional innovation ecosystems worldwide and connects them to Silicon Valley. Led by founder and CEO Anis Uzzaman, Pegasus leverages its extensive global network and deep tech expertise to drive corporate innovation and help emerging tech companies achieve industry leadership.

Pelion Venture Partners, based in Salt Lake City, Utah, is a prominent venture capital firm that has been active since 1986. The firm focuses on early-stage investments in technology sectors, including enterprise software, digital media, SaaS, and cloud services. Pelion has made over 300 investments, with notable exits such as Cloudflare, Domo, and Venafi. Their investment strategy involves supporting startups with innovative solutions and strong growth potential. Pelion typically invests in seed and Series A rounds, providing the necessary capital and strategic support to help companies scale. Recent investments include companies like Jump and Cartwheel​.

Pentas Ventures is an early-stage venture capital firm based in Los Angeles, primarily focusing on investing in the future of commerce and technology. Founded in 2021 by entrepreneurs Emir Dereli and Emir Talu, Pentas Ventures backs innovative startups that are shaping the next generation of products and services. The firm typically invests during the seed and Series A stages, writing checks of up to $500K and reserving additional follow-on capital up to $1 million for promising portfolio companies. The firm's portfolio reflects its commitment to supporting transformative companies, with investments spanning sectors like retail technology, consumer goods, and fintech. Notable companies backed by Pentas Ventures include Blank Street, a fast-growing coffee startup, The Expert, a digital platform connecting homeowners with design professionals, and TellySprinter, a forward-thinking technology service. What sets Pentas Ventures apart is the founders' hands-on approach, stemming from their experience as operators and early-stage investors. The team is deeply involved in helping portfolio companies achieve product-market fit and scale efficiently. Their focus on North American companies highlights their strong regional presence, though they occasionally support global ventures. Pentas Ventures is recognized for fostering long-term partnerships with founders, helping them build essential, sustainable products in evolving industries.

Pentathlon Ventures is a Pune-based seed-stage venture capital fund founded in 2020 and dedicated exclusively to Indian B2B SaaS companies. The firm was co-founded by seven entrepreneurs and industry veterans with more than 150 years of combined operating experience: Gireendra Kasmalkar, Sandeep Chawda, Saurabh Lahoti, Madhukar Bhatia, Ashok Mayya, Hemant Joshi, and Shashank Deshpande, all drawn from companies including Globant, Clarice, Sapience, Symphony, Veritas, and Rising Pharma. This operator-heavy founding team gives Pentathlon an unusually hands-on governance and go-to-market role at the board level, which is central to the firm's positioning. Fund I closed at INR 76 Cr in August 2021 and deployed into 23 B2B SaaS startups. Fund II was launched with a headline target of INR 450 Cr and held its final close at INR 255 Cr (approximately $54.4 million) to back an additional 25 companies. Across its two funds, Pentathlon has made 31 investments. Named portfolio companies include Deeptek, Rezolve, Spyne, Dista, TurboHire, ShopSe, AyushPay, TreZix ($2 million round, January 2025), and SuperProcure (the most recent investment, in February 2026). Five new investments were executed in 2025 and one so far in 2026. The firm's investment focus covers enterprise digital transformation, e-commerce enablement, fintech, vertical SaaS, applied AI, sustainable tech, and healthtech. Pentathlon's founding philosophy holds that the best advisors for a SaaS founder are experienced SaaS operators, not career investors. The partners take an active role in product strategy, hiring, go-to-market design, and customer introductions, treating each portfolio company as a long-term partnership rather than a financial position.

Pentech Ventures is a premier venture capital firm headquartered in Edinburgh with a strong presence in London. They specialize in seed and early-stage investments, primarily targeting innovative software companies. Known for their notable exits like FanDuel, Nutmeg, and Maxymiser, Pentech has a reputation for nurturing companies that redefine their industries. Pentech focuses on UK-based startups across various software domains, including fintech, AI, and SaaS. They typically invest around £1M, often leading rounds and collaborating in syndicates. Their strategy involves not just capital infusion but also strategic guidance, leveraging their extensive network to introduce additional funding partners for subsequent growth stages. The team is led by founding partner Eddie Anderson, alongside experts like Alexander McKinnon and Craig Anderson, all based in Edinburgh. Their deep expertise spans machine learning, enterprise infrastructure, and SaaS business models, providing invaluable support to portfolio companies. For startups seeking investment, Pentech values ambitious leadership and category-defining potential. They prefer to be approached with clear, concise pitches that demonstrate strong market potential and scalability. Active and engaged, Pentech remains a dynamic force in the venture capital landscape, continuously seeking to empower the next generation of software pioneers.

People Ventures is a venture capital firm that specializes in supporting early-stage startups by taking a hands-on, operational approach. Based in Copenhagen, they focus on more than just providing capital—they actively engage with their portfolio companies by embedding a dedicated Venture Developer (VD) into the startup's team. This model allows them to stay closely involved with founders, driving commercial and operational execution from within the company. Their unique focus is on shaping and scaling innovative businesses, particularly in fields such as healthcare and tech. People Ventures is known for breaking away from traditional VC paradigms, emphasizing deep collaboration with founders to navigate the daily challenges of running a startup. Their approach enables founders to focus on scaling their businesses while benefiting from the expertise and guidance of industry experts and experienced entrepreneurs.

The Greenhouse Accelerator is a sustainability-focused initiative by PepsiCo that operates globally, including in the Asia-Pacific (APAC) region. Launched in 2023, this program is designed to support startups that develop innovative solutions aligned with PepsiCo's goals of achieving net-zero emissions by 2040 and promoting sustainable practices across their supply chain. The accelerator offers mentorship, financial grants, and networking opportunities to help startups scale their impact. In APAC, where rapid economic growth presents unique sustainability challenges, the Greenhouse Accelerator plays a critical role in fostering innovation. By partnering with startups focused on the circular economy, sustainable agriculture, and climate action, the program helps address significant environmental issues while also contributing to PepsiCo's broader Pep+ (PepsiCo Positive) strategy. This strategy emphasizes positive agriculture, sustainable packaging, and healthier consumer choices, aiming to transform PepsiCo’s business operations worldwide. The accelerator’s success is evident in its global engagement, with over 86 companies having participated across various regions since its inception in 2017. In the APAC region, the program has already supported several pilot projects, demonstrating the power of collaboration between large corporations and agile startups to drive sustainability at scale. Startups in the program receive an initial grant of $20,000, with the potential for further funding based on their success in developing impactful, scalable solutions.

Perceptive Xontogeny Venture Fund (PXV) is the early-stage life-sciences venture capital platform of New York-based Perceptive Advisors, operated in strategic partnership with Boston-based accelerator and operating company Xontogeny. Perceptive Advisors launched its venture strategy with Perceptive Xontogeny Venture Fund I in 2018, an oversubscribed $210 million vehicle backed by endowments, foundations, family offices, and institutional investors. Fund II closed in May 2021 at $515 million, bringing the combined platform to more than $700 million dedicated to financing early-stage private life-sciences companies. The Investment Committee is anchored by Joe Edelman (CEO of Perceptive Advisors), Adam Stone (CIO of Perceptive Advisors), and Chris Garabedian (Portfolio Manager and Chairman and CEO of Xontogeny), alongside operating partners Fred Callori and Ben Askew, PhD. The platform leads rounds and invests typical checks of $10 million to $20 million, targeting 8 to 10 concentrated positions per fund across biotechnology, medtech, digital health, and healthcare tools and services. Across its 27 investments, PXV has backed Landos Biopharma (the first Xontogeny company, acquired by AbbVie in May 2024 as the platform's headline exit), Lexeo Therapeutics (which entered a partnership with venBio Partners in June 2025 providing up to $40 million for novel cardiac RNA therapeutics), and other early-stage therapeutics companies. Xontogeny's operating role distinguishes PXV from traditional life-sciences funds: the platform provides deep operational support from the pre-company stage through clinical and commercial scale-up, allowing the investment team to co-build companies alongside founders rather than simply writing checks and attending board meetings.

Pereg Ventures is an early-stage cross-border venture capital firm founded in 2012 by Managing Partners Itzhak Fisher and Ziv Ben-Barouch and headquartered in Midtown Manhattan, with deep operational roots in Israel. Venture Partner Mark Leiter complements the founding team, which collectively brings more than three decades of investment and startup operating experience across more than 100 prior investments. The firm invests in disruptive B2B data-driven ventures that accelerate consumer-facing enterprises, with a focus on retail technology, e-commerce, digital marketing, and consumer-behavior analytics. Pereg's core thesis leans on its dual geographic footprint: sourcing raw technological innovation from Israel while providing US market access, distribution, and go-to-market expertise to portfolio companies. The firm leads rounds in seed through Series B stages. Pereg Ventures Fund I closed in February 2015 with anchor support from Nielsen, which provided a significant LP commitment, alongside Tata. The portfolio consists of 18 companies including one unicorn: Bringg, which reached unicorn status in 2021 four years after Pereg's first investment. Additional portfolio companies include Onclusive, RetailNext, Nutrino, CB4, Engage3, Discuss.io, Crosswise, Syte, ChannelEyes, Cielo24, OurCart, Quaero, and Staq. The firm has produced one IPO and six acquisitions. The most recent exit was RetailNext in January 2025, and the most recent new investment was a December 2024 controlling-stake acquisition of AI apparel commerce platform Syte, co-led by Pereg with Magma VC, MizMaa, and Stardom Ventures. Pereg's Israel-US bridge model gives it early access to enterprise data and analytics technology coming out of Israel's deep talent pool in intelligence and cybersecurity, which it then connects to some of the world's largest retail and consumer brands in the United States.

Peregrine Ventures is Israel's first dedicated healthcare-focused venture capital fund, founded in 2001 in Or Yehuda by serial entrepreneur brothers Eyal Lifschitz (Co-Founder and General Managing Partner) and Boaz Lifschitz (Co-Founder and General Partner), who previously co-founded biomedical device companies Visioncare Ophthalmic Technologies and BioControl in the 1990s. The firm today manages approximately $600 million in assets across a multi-fund platform that pairs early-stage venture investing with Peregrine Growth, a $300 million late-stage life-sciences fund launched in November 2020, plus earlier funds including a $115 million med-tech vehicle. Partners Tamir Tal, Lior Shahory, David Eldar, and Shiran Tehila Mashiah complement the founding team. A distinctive feature of the platform is its embedded synergy with the Incentive Incubator, giving portfolio companies deep operating support from the pre-company stage through clinical and commercial scale-up. Peregrine leads rounds and has made approximately 172 investments into around 75 active and realized portfolio companies, with one unicorn, one IPO, and 16 acquisitions to date. Notable outcomes include Insightec, Quicklizard, and Eledon. Startup Nation Central named Peregrine Israel's most active healthtech investor for 2024, based on 15 strategic health-tech deals. The investment scope covers life sciences broadly: healthcare, digital health, medical devices, therapeutic devices, pharma, biotechnology, and medical software. Recent investments include Lutris Pharma ($30 million, January 2025) and Aluma Healthcare in September 2025. Peregrine's 25-year track record in Israeli healthcare and its deeply integrated incubator model create a continuum from scientific concept to clinical validation that few other investors can offer. By maintaining active involvement at every stage from incubation through growth equity, the firm builds durable portfolio relationships that extend well beyond a standard investment horizon.

Perle Ventures is a Sydney-based growth-stage technology venture capital firm founded in 2013 by Co-Founder and Chairman Shayne Smyth, the entrepreneur who founded and later divested Cover-More, Australia's largest integrated travel insurance and medical assistance provider, and Co-Founder and Managing Director Michael An, who brings more than 20 years of experience as a founder, investor, board member, and adviser across technology, education, telecommunications, and financial services. The firm operates as a compact three-person platform and concentrates on seed and growth-stage investments in Australian technology companies, with selective exposure to Singapore and the United States. Sector focus spans enterprise applications, fintech, high tech, retail, marketplace, and vertical SaaS. Perle's portfolio numbers roughly 25 investments including one unicorn, Dapper Labs, and realized outcomes of seven IPOs and three acquisitions. Notable portfolio names include Coinbase, Dapper Labs, FiscalNote, TradeGecko, Simple, Spriggy, Academy Xi, and Wattwatchers. The most recent documented investment is Dapper Labs in March 2022, with no publicly disclosed new deployments since, suggesting the firm is operating in portfolio-management mode. Perle Ventures benefits from its founders' complementary backgrounds: Smyth's experience scaling and exiting a major Australian consumer business provides commercial pattern recognition, while An's multi-decade technology investment career provides deal-origination breadth. Together they offer founders access to corporate networks, capital market relationships, and cross-border connectivity spanning Australia, Singapore, and the United States, making Perle a value-added partner for technology companies scaling from the Asia-Pacific region into global markets.

Perot Jain is a Dallas-based early-stage venture capital firm co-founded by Ross Perot Jr. and Anurag Jain in 2014. The firm primarily focuses on investing in innovative and disruptive startups within the healthcare, mobility, business services, and tech-enabled B2B sectors. Notable investments include companies like Access Healthcare, specializing in healthcare IT solutions, and Worlds, which creates AI-generated models for business process optimization. Other significant portfolio companies are Spacee, which offers virtual store walkthroughs, and Booster, a mobile fuel delivery service. Perot Jain typically invests up to $500,000 in seed and Series A rounds, aiming to support scalable businesses located in the United States. The firm leverages its extensive network and operational expertise to provide more than just capital, offering strategic guidance and resources to help startups achieve transformational growth. The team at Perot Jain includes a mix of founders, executives, and industry experts who work closely with entrepreneurs to drive innovation and impact. The firm has made over 70 investments and maintains a strong presence in the North Texas startup ecosystem, contributing to the region's growth as a national center for technology and innovation.

Persol Venture Partners is the corporate venture capital arm of the Japan-based Persol Group, a leader in HR services and workforce solutions. Launched as a strategic initiative, Persol Venture Partners focuses on investing in startups that are innovating in technology, staffing, and digital services, aligning with Persol Group's mission of enhancing the future of work. The firm primarily invests in early-stage companies across sectors such as HR technology, fintech, and marketplace platforms. Based in Tokyo, Persol Venture Partners typically targets investments in Japan and Southeast Asia but also backs global startups. The firm has made notable investments in companies like WAmazing, a tourism app, and NodeFlair, a recruitment software platform. Their investment approach often involves not only providing financial backing but also leveraging Persol Group's extensive industry network to support the growth and scalability of portfolio companies. Persol Venture Partners invests across various stages, including seed and Series A, typically participating in rounds that range from $2M to $60M. The firm is deeply committed to fostering open innovation and creating new business opportunities that will redefine the future of work and staffing industries​.

Perspectiv Ventures is a Singapore-based early-stage venture capital firm founded in 2015 and led by Managing Partner and Chief Strategist GheeHoe Cheng. The firm provides seed and early-stage funding to technology-driven ventures across three core thematic verticals: healthtech and medtech, fintech and blockchain, and AI and robotics, operating primarily across Southeast Asia with additional connectivity to the United States. Beyond capital, Perspectiv offers strategic guidance on growth, scaling, and governance in the digital business and smart-services landscape, typically participating in follow-on rounds as startups mature. The team of five includes one Partner, two Venture Partners, and one Principal, providing geographical and sectoral coverage across Singapore and the US. The firm's internal decision framework is branded 'MTTM' covering Market, Talent, Technology, and Momentum, giving its evaluation process a structured lens that goes beyond product-market fit to assess the full commercial trajectory of each investment. Perspectiv has made 13 investments across healthtech, fintech, AI, blockchain, hardware and robotics, and SaaS. Named portfolio companies include Aniday, a Southeast Asian HR and recruitment SaaS platform, and Wellcare, a clinics and outpatient-services operator. The most recent publicly documented investment is Aniday in September 2019, with no new investments publicly recorded in 2024 or 2025. Perspectiv Ventures occupies a niche as an early specialist in the Southeast Asian digital economy, having established its position in Singapore before the current wave of larger regional and international funds entered the market. GheeHoe Cheng's background in both strategic advisory and early-stage investing gives the firm a practitioner's perspective on what it takes to commercialize technology across Southeast Asia's fragmented regulatory and consumer landscape.

Peterson Ventures is a seed-stage venture capital firm that helps entrepreneurs build successful businesses from the ground up. Headquartered in Utah with an additional office in the Bay Area, Peterson Ventures focuses on SaaS, digital commerce, fintech, and healthtech sectors. The firm typically invests $250K to $1M in early-stage startups, aiming to bridge the gap between angel investors and traditional venture capital. Founded in 2008 as part of the Peterson Partners platform, Peterson Ventures has invested in over 200 companies, including notable names like Allbirds, Ethos, Lucid Software, and HireVue. The firm recently raised $140 million for its fourth fund and its first opportunity fund, allowing continued investment in their best-performing portfolio companies as they scale. The firm is led by Managing Director Ben Capell, with a team of experienced partners and associates who bring diverse backgrounds in entrepreneurship, investment banking, and corporate strategy. Peterson Ventures is known for its founder-first approach, providing not just capital but also strategic guidance and support to help startups overcome challenges and achieve growth.

Petri Bio is a biotechnology company focused on developing next-generation therapeutics derived from gut microbes. The company leverages the vast genetic information within the microbiome to discover and develop novel treatments for challenging diseases such as inflammatory bowel disease (IBD) and fatty liver disease. These diseases often have limited effective treatments, making Petri Bio's work particularly impactful. Founded by Shu Li, a Ph.D. in plant biology, and Joseph Schinaman, a biomedical researcher, Petri Bio is committed to using microbial compounds to create new medicines. Their approach involves mining microbial genomes for peptides with therapeutic potential, which they believe could lead to breakthroughs in treating various conditions that are currently underserved by existing pharmaceutical solutions. Petri Bio has also been involved in the development of treatments related to COVID-19, using their platform to identify compounds that could potentially neutralize the virus. Their work has garnered attention and interest from major pharmaceutical companies, and they continue to expand their pipeline to include other critical areas of healthcare.

Pfizer Venture Investments (Pfizer Ventures) is the corporate venture capital arm of Pfizer Inc., established in 2004 and headquartered in New York. The platform carries a $900 million total capital commitment, including a $600 million top-up announced in Q4 2021, and backs private companies at all stages of development with a strong bias toward early-stage therapeutics and platform technologies. Investment priorities mirror Pfizer's therapeutic areas: inflammation and immunology, internal medicine, oncology, and neuroscience, extending into platform technologies, diagnostics, drug delivery, pharmaceutical services, and healthcare IT. Roughly 25 percent of available capital, approximately $150 million, is explicitly earmarked for early-stage neuroscience investments. Across approximately 200 investments, Pfizer Ventures has built a concentrated neuroscience portfolio including Aquinnah, Autifony, Cortexyme, MindImmune, Mission Therapeutics, and Neuronetics. The platform leads rounds and invests globally, though deployments skew toward US-based companies. Recent notable investments include Curve Therapeutics (GBP 40.5 million Series A, led in February 2024), Enara Bio ($32.5 million Series B co-led with M Ventures in October 2024), Enlaza Therapeutics ($100 million Series A syndicate in September 2024), OTR Therapeutics ($100 million Series A for a Chinese biotech in June 2025), and Crossbow Therapeutics in March 2026 as the most recent disclosed investment. Pfizer Ventures serves as a strategic window on early-stage innovation across life sciences globally. Portfolio companies benefit not only from capital but also from Pfizer's regulatory expertise, clinical development networks, and therapeutic-area know-how, creating pathways to partnership, licensing, and acquisition that financial-only investors cannot offer.

PGV (Punja Global Ventures) is a venture capital firm based in Houston, Texas, founded in 2022. The firm focuses on early-stage investments, particularly in industries such as healthcare, media, business productivity software, and financial technology. PGV seeks to back innovative companies that have the potential to transform industries, leveraging technology and creative solutions to drive growth. PGV’s investment strategy revolves around identifying promising startups in emerging sectors and providing them with the capital and resources needed to scale. The firm has made a range of investments across different regions, with a particular emphasis on companies based in the United States, Singapore, and Seychelles. Some of its notable investments include companies like Styrk AI, a network management software firm, and MDVerse, which focuses on healthcare discovery tools. The team at PGV, led by managing partner Manmeet Singh, brings extensive experience from various sectors, combining business development with strategic advisory to help portfolio companies thrive. The firm typically participates in seed and early-stage rounds, providing not just capital but also mentorship and access to a vast network of industry connections. Since its founding, PGV has demonstrated a strong commitment to fostering innovation and supporting forward-thinking entrepreneurs who are reshaping their respective industries. Their approach emphasizes long-term value creation and partnerships with founders who exhibit strong leadership and vision.

Phenomen Ventures (Phenomen VC) is a mid-to-late-stage global venture capital firm founded in 2012 and based primarily in London, United Kingdom. The firm describes itself as investing in 'internet and tech phenomenons' — category-leading, fastest-growing companies across the United States, Europe, and Israel. Phenomen focuses on information technology, SaaS, and consumer internet, predominantly at Series A and Series B stages, with particular historical emphasis on Germany-based startups. The firm operates with a lean team of three partners and has more than $300 million in committed capital across 22 investments, with portfolio companies reaching customers in 35 countries. The portfolio carries an enviable track record with two major European consumer-tech IPOs: HelloFresh (listed on Euronext in November 2017 at a $1.91 billion market cap) and Delivery Hero (listed on the Frankfurt Stock Exchange at a $5.01 billion market cap). Four portfolio companies have been acquired in total, including FREE NOW, which was acquired by Lyft for $199 million in April 2025. Other disclosed portfolio companies include Arbox (business and productivity software, most recent investment in September 2025), Constru, Foodpanda, and LightYX. Phenomen Ventures applies a concentrated, conviction-driven approach to identifying category-defining companies at the Series A and B junctures where growth trajectories become apparent but valuations remain constructive. The firm's track record in consumer internet and food technology, combined with its pan-European perspective and US and Israeli deal connectivity, positions it as a specialist partner for founders seeking a globally networked investor with demonstrated success in scaling internet businesses to IPO.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Philips Venture Capital Fund (Philips Ventures) is the corporate venture capital arm of Royal Philips, the Dutch multinational health technology company. Founded in 1998 and based in Amsterdam at the Amstelplein 2 Breitner Tower, Philips Ventures deploys strategic capital into early- to growth-stage health technology startups whose innovations complement Philips' global healthcare portfolio and digital transformation agenda. The fund is led by Managing Partner Nate Harrington and operates with a lean two-person team at the fund level. As a corporate and strategic investor, Philips Ventures leverages Philips' deep domain expertise, global commercial footprint, and research and development capabilities to add value to portfolio companies beyond capital alone. Investment activity focuses on Series A and Series B rounds in digital software and technology-enabled healthcare services, predominantly in US-based startups with global activity. The fund has made 22 investments across healthtech, AI, and medical devices and hardware. Notable portfolio companies include PreciseDx (diagnostic equipment, latest investment as part of a Series B-II round in June 2025 as the firm's most recent disclosed deployment), Endovascular Engineering, and R3 Vascular. Recorded exits include Carevive Systems in June 2024 and ALung, acquired by LivaNova in May 2022. The firm currently states it is not investing in development-stage or pre-clinical businesses. Philips Ventures focuses on innovations that can reduce costs, improve clinical outcomes, and transform the patient and clinician experience in ways that align with Philips' strategic roadmap. Portfolio companies benefit from the potential to pilot solutions within Philips' customer network, access the firm's technical talent, and leverage its global healthcare commercial relationships across hospitals, imaging centers, and health systems worldwide.

PhillipCapital, established in 1975 and headquartered in Singapore, is a prominent global financial institution with a vast presence in 15 countries, including financial hubs like Chicago, London, and Tokyo. The firm provides a diverse range of financial services such as stockbroking, asset management, insurance, foreign exchange, real estate, and more. With over $35 billion in assets under management, PhillipCapital serves both individual and institutional investors, offering tailored solutions to meet various investment needs. PhillipCapital has played a pioneering role in financial innovation, being the first to introduce online trading (POEMS) to Singapore in 1996 and expanding its reach through cutting-edge financial products like contracts for difference (CFDs) and exchange-traded funds (ETFs). The firm's extensive product offerings include equities, fixed income, and commodities, supporting clients' growth across different asset classes. Notable investments by PhillipCapital include its co-lead financing for fintech startup Helicap, which highlights its focus on backing innovative, technology-driven businesses. The firm also expanded into new markets, acquiring Hwang-DBS Commercial Bank in Cambodia and rebranding it as Phillip Bank, now one of Cambodia’s largest banks. PhillipCapital continues to prioritize diversification and innovation while maintaining a client-centric approach, making it a leader in Asia’s financial landscape with a global reach. The company’s commitment to providing personalized financial services is evident through its ongoing expansion and award-winning brokerage services.

Phirst Market Ventures is a venture capital firm based in Philadelphia, Pennsylvania, dedicated to supporting women of color entrepreneurs. The firm provides integrated capital in the form of grants, loans, and patient equity to early-stage companies across various industries, including technology and health & beauty products. Phirst Market Ventures aims to catalyze growth by offering resources and connections necessary for scaling these businesses​. The firm was co-founded by Tanya T. Morris, Jason Ray, and Diane Cornman-Levy. It focuses on startups with at least one Black or Brown female founder or C-Suite executive, emphasizing the importance of diverse management teams. The investment strategy targets companies with long-term visions and potential for significant market impact, particularly those operating between Washington, DC, and New York City, with a strong focus on Philadelphia. Phirst Market Ventures is actively investing and has supported 12 companies led by underestimated founders. Their portfolio includes innovative startups like Biolatice, Trapezium Math, and Ashay Handbags & Wallets, which reflect their commitment to fostering diversity and inclusion in entrepreneurship​.

Phoenix Capital Ventures (PCV) is an early-stage venture capital firm focusing on companies within the sports, gaming, human performance, and media industries. Leveraging over 35 years of industry experience, PCV partners with entrepreneurs to build industry-leading companies. Their investment strategy involves supporting businesses through both capital and strategic guidance, helping them scale and achieve market leadership. PCV has built an impressive portfolio, backing a range of innovative companies like Prize Picks, a popular daily fantasy sports platform, Flexia, a connected fitness company in the Pilates space, and Ghost, a sports and gaming performance brand. The firm also has a strong track record of successful exits, including companies like THUUZ and Manifest Pharmacy. Headquartered in Atlanta, PCV is led by founder and managing partner Andrew Steinberg and managing director Adam Lewites. They are supported by a diverse team of advisors, including professionals with expertise in sports, healthcare, and business development. This extensive network allows PCV to provide unique insights and resources to their portfolio companies, helping them navigate challenges and seize growth opportunities. PCV typically invests at the seed and Series A stages, offering both financial and operational support to companies that align with their vision of innovation and industry disruption. Their approach emphasizes building strong, long-term partnerships with founders to drive sustainable growth in emerging markets​.

Phoenix Contact Innovation Ventures (PCIV) is the global corporate venture capital arm of the Phoenix Contact Group, a German industrial technology company specializing in components and systems for electrical connection technology and industrial automation. Founded in 2015 and headquartered in Blomberg, Germany, PCIV identifies, invests in, and scales highly disruptive digital and technology-driven business models that align with Phoenix Contact's vision of a world powered by affordable renewable energy and optimized for industrial energy efficiency. The firm writes initial checks between EUR 0.1 million and EUR 2.5 million and participates in early-stage through second-stage rounds, focusing primarily on European startups. Investment themes include IoT and industrial hardware, industrial SaaS, big data, AI and machine learning, manufacturing technology, electrical connection, industrial automation, and renewable-energy infrastructure. The firm has made 18 disclosed investments over its lifetime, with approximately 10 active portfolio companies as of mid-2025. Notable portfolio companies include aedifion (smart-building SaaS, most recent investment in June 2025 as part of its Series B round in which aedifion raised EUR 17 million to cut real estate costs and CO2 emissions), eologix-ping (wind-turbine blade health monitoring sensors, strategic round in May 2024), and Digital Spine (energy-sector digital platform). PCIV frequently co-invests with Robert Bosch Venture Capital, KfW, and KPN Ventures. Phoenix Contact Innovation Ventures positions itself as a strategic partner that complements capital with access to Phoenix Contact's global industrial and electrical engineering expertise, customer relationships, and supply chain. Founders backed by PCIV gain a corporate partner with deep technical credibility in industrial and energy markets, which can meaningfully accelerate commercial adoption within European infrastructure and manufacturing sectors.

Phoenix Court Group, formerly known as LocalGlobe, is a prominent venture capital firm based in London that has rebranded to reflect its expanded scope and increased funding capacity. The firm has successfully raised $500 million across four distinct funds aimed at supporting tech startups from the seed stage to IPO and beyond. These funds include LocalGlobe, which focuses on pre-seed and seed investments, and Latitude, which targets early growth and Series B/C stages. Additionally, Solar is dedicated to scale-up investments, helping companies transition from private to public markets, while Basecamp supports emerging early-stage funds, angels, and solo general partners across diverse geographies including Africa, Asia Pacific, Europe, India, Israel, and the US​. Phoenix Court Group emphasizes investing in the "New Palo Alto," a term used for the innovation ecosystem in northwest London, particularly in Somers Town. This region is considered the third-largest tech innovation hub globally, after the Bay Area and Beijing. The firm aims to address the underinvestment at the breakout and scale-up stages in this area. Their strategy is designed to build a comprehensive pipeline that supports companies from early stages through to public offerings, ensuring continuous growth and development. Phoenix Court Works, the philanthropic arm of the group, supports local community initiatives in health, education, and environmental sustainability by allocating 10% of the management company’s profits and 2% of carry from all funds. This initiative has supported 23 organizations to date, focusing on improving health and wellbeing, promoting education and inclusion, and addressing climate and environmental issues.

Phoenix Venture Partners (PVP) is a Silicon Valley-based venture capital firm founded in 2009 and headquartered in San Mateo, California, with satellite offices in Singapore and Cambridge, Massachusetts. The firm specializes in taking transformative hard-technology innovations in advanced materials, novel devices, innovative manufacturing processes, and state-of-the-art tools from proof-of-concept to commercialization. Founder and Managing General Partner John Chen leads a team of seven, including five partners. PVP's core thesis targets what the firm calls Convergent Tech: the intersection of advanced materials, biology, and hardware with advanced computation and AI, investing in early-to-revenue-stage companies tackling pain points in computing, electronics, transportation, energy, industrial applications, and life sciences. Typical checks range from $100,000 to $7.5 million, and the firm leads Series A rounds. Over its 19-year history, PVP has made 85 investments, averaging two new investments per year in the last decade, and has recorded 3 IPOs and 17 acquisitions. Notable portfolio outcomes include AbSci (PVP led the 2016 Series A; AbSci listed on NASDAQ in July 2021 at a $1.45 billion market cap), NBD Nanotechnologies, and COTSWORKS (exited in July 2025). Recent investments include UbiQD (Series B-II in February 2026 as the most recent disclosed investment), Qolab (superconducting quantum computing), ORAN Development, and Nanofiber Quantum Technologies. Phoenix Venture Partners provides founders with hands-on support in business development, IP strategy, recruitment, and exit planning, leveraging a global network of strategic partners spanning manufacturing, government, and enterprise markets. Its specialist positioning in hard tech and advanced materials makes it one of the few firms capable of leading early institutional rounds in deep-science companies that require both technical diligence and long commercialization timelines.

PhotonDelta, based in Eindhoven, Netherlands, is a leading accelerator in the integrated photonics industry. Founded in 2018, the organization plays a crucial role in building Europe's photonics ecosystem by fostering startups and scale-ups that are developing photonic integrated circuits (PICs). These circuits are essential for innovations across various sectors, including healthcare, telecommunications, and autonomous vehicles. PhotonDelta's strategy is centered around a long-term vision to establish the Netherlands as a global leader in photonics. The organization has secured over €1.1 billion in public and private investments to support its mission. This funding is used to scale up production, support the creation of 200 startups, and build infrastructure and talent across Europe by 2030. PhotonDelta also recently launched PhotonVentures, a €60 million venture capital fund aimed at early-stage photonic chip companies, with plans to expand the fund to €150 million. PhotonDelta's ecosystem includes 70 organizations, offering a complete value chain from design to manufacturing. Their efforts extend globally, as evidenced by the opening of an office in California to enhance collaboration between European and North American photonics industries.

PHX Ventures is a seed-stage venture capital firm based in Tempe, Arizona, founded in 2018 by software entrepreneur Gregg Scoresby, also the founder of CampusLogic, to fill a structural gap in the Arizona software ecosystem: institutional-quality seed capital for high-growth local B2B SaaS companies. Operating Partner Chris Chumley, previously Chief Operating Officer at CampusLogic, complements Scoresby's operating background. PHX Ventures is Arizona's most active software investor, investing exclusively in B2B SaaS and leading or co-leading seed rounds of $1 million to $5 million. The firm's sweet-spot target is Arizona-based B2B SaaS companies with annual recurring revenue of $100,000 to $1 million that are on a credible path to institutional growth. PHX Ventures' oversubscribed Fund II closed at $25.4 million in 2023, backed by successful Arizona software entrepreneurs, executives, advisers, and principals from top-tier US growth-equity firms. The firm also operates a venture studio that builds SaaS companies in-house and has a goal of investing in 30 B2B software companies by 2030. As of 2025, PHX has made 16 or more investments with 12 Arizona-headquartered companies. Portfolio companies span enterprise applications, vertical SaaS, fintech, healthtech, and AI. Named portfolio companies include Rivia Health, Better Agency, Nurture Boss, RTA/Fleet360 (Series A in April 2025), and Fluint (most recent disclosed investment in August 2025). PHX Ventures combines founder-operator credibility with proximity to the Arizona tech ecosystem, bringing a practical understanding of software business-building rather than purely financial expertise. Its fund-plus-studio model gives it access to both market-sourced deals and proprietary company creation, expanding the pipeline relative to a traditional seed fund.

USA, the UK, and Russia. The firm specializes in early-stage investments, focusing on high-tech sectors such as AI, mobility, energy, biotech, and space technology. Phystech Ventures supports startups that leverage scientific advancements to create disruptive solutions and transform industries. The firm's portfolio includes investments in various industries like the internet of things, connected platforms, automotive, education technology, cybersecurity, sensors, robotics, and energy tech. Notable investments include companies such as Osome, H2Drone, Geosteering Technologies, and Coda Devices​​. Phystech Ventures is driven by a team of experienced professionals, including Daniel Shaposhnikov, who leads AI/ML, energy, and mobility verticals, and Ivan Protopopov, who oversees life sciences and space tech investments​.

Phyto Partners is a venture capital firm based in Boca Raton, Florida, focused on the cannabis industry. Since its founding in 2015, the firm has invested in around 30 companies across the cannabis value chain. Their strategy prioritizes ancillary businesses, which provide essential solutions to support licensed operators, such as advertising technology, agricultural innovations, biotechnology, SaaS, and medical dosing technology. Phyto Partners takes an active role beyond just providing capital, offering strategic support, networking, and business development assistance to help their portfolio companies grow. Their investments span various sectors, including branded products, cannabis delivery services, and data analytics. The firm is known for helping companies navigate the highly regulated cannabis market, seeing compliance and technology solutions as key growth areas. In addition to their cannabis focus, Phyto Partners has expanded into brain health and psychedelics with their "Phyto Psyche" fund, recognizing the growing interest in neurowellness and mental health treatments.

Pi Campus is a venture capital firm based in Rome, Italy, that specializes in investing in early-stage startups focused on artificial intelligence (AI) and tech innovations. Founded by Marco Trombetti, Isabelle Andrieu, and Gianluca Granero, Pi Campus originated from Translated, a pioneering AI-driven translation service. The firm primarily invests in startups that apply AI to disrupt traditional industries, especially those perceived as slow-moving, and supports them with funding, mentorship, and access to a vast international network. Pi Campus typically invests between €50,000 and €500,000 in exchange for equity stakes of 1% to 10%, targeting startups in Europe and the U.S. with a strong focus on AI applications. Their portfolio includes companies like Boom Supersonic, which is working on sustainable supersonic travel, and Skymind, an AI ecosystem builder. In addition to financial investment, Pi Campus provides a nurturing environment for startups, including workspace in luxury villas converted into offices, and mentorship through their School of AI, which trains engineers on real-world problems with the support of global tech leaders like Google and Facebook. Pi Campus places a significant emphasis on fostering innovation and diversity, offering a collaborative platform for AI enthusiasts and entrepreneurs who combine design, technology, and emotional intelligence to create impactful products​.

Pi Ventures, founded in 2016 and based in Bengaluru, India, is a venture capital firm focused on early-stage investments in deep tech startups. The firm specializes in sectors such as artificial intelligence, machine learning, the Internet of Things (IoT), and healthcare. Notable investments by Pi Ventures include companies like Agnikul, an aerospace startup; SwitchOn, which focuses on industrial automation and machine learning; and Zero Cow Factory, a biotech company developing sustainable food products. Pi Ventures has invested in a total of 42 companies and has made significant exits, including Zenatix Solutions through a merger and acquisition. The firm was founded by Manish Singhal and Umakant Soni, and the leadership team includes Managing Directors Roopan Aulakh and Shubham Sandeep. Pi Ventures is known for backing innovative startups and supporting them through their growth phases with a combination of capital and strategic guidance.

Picks and Shovels is a venture capital firm based in Santa Monica, California, founded in 2022 by Josh Schlisserman. The firm focuses on investing in pre-seed and seed stage startups that develop tools and infrastructure for other businesses, particularly those involved in fintech and cryptocurrency sectors. This "picks and shovels" investment strategy is analogous to selling shovels during a gold rush, focusing on essential support and infrastructure rather than the end products themselves​. Picks and Shovels invests in companies such as Assistiv Labs, Blip Labs Technologies, and Openlytics, which provide services ranging from accessibility tools to fintech solutions and data analytics platforms​​. The firm typically writes checks ranging from $1 million to $2.1 million for seed rounds, aiming to empower foundational technology startups that can support broader market growth.

Picus Capital, founded in 2015 and headquartered in Munich, Germany, is an early-stage venture capital firm with a long-term investment philosophy. The firm focuses on technology-driven sectors such as financial services, HR, energy & climate, healthcare, logistics & mobility, real estate & construction, crypto & web3, deep tech, and e-commerce. Picus Capital has made significant investments in companies like Ledge, Spot My Energy, Cove Living, Poolit, and Alasco, among others. Their portfolio spans across 20+ countries with a diverse range of startups that are innovating in their respective fields. The firm's unique approach emphasizes close partnerships with their portfolio companies, assisting them with strategic decisions and operational challenges. With offices in Munich, London, New York, Beijing, and other key locations, Picus Capital is well-positioned to support global growth and expansion. The firm is led by co-founders Robin Godenrath, Alexander Samwer, and Jeremias Heinrich, who bring extensive experience and a strong entrepreneurial mindset to the table. Their team is dedicated to helping daring technology companies build successful, global enterprises that challenge the status quo and shape the future​

PieLAB Venture Partners is an investment management and venture capital firm based in Fortitude Valley, Brisbane, Australia, founded in 2015 and operating since 2016. PieLAB launched as Australia's first dedicated proptech venture capital firm, deploying an initial $20 million fund targeting businesses that serve the real estate sector. After fully deploying that first fund, PieLAB raised a $21 million second vehicle, the PieLAB REIVC fund, backed by prominent Australian residential real estate groups including McGrath, Ray White, and Belle Property, representing more than 250 businesses. Managing Partner Chris Rolls, who previously built and exited four businesses including Rental Express, Queensland's largest residential property management business, leads an 18-person team of six partners. The firm has made 17 investments across proptech and real estate technology, SaaS, B2B services, and software. PieLAB leads Series A rounds in Australian startups. Named portfolio companies include Cloudstaff, Idea 11, Absolute Balance, and Commercial Fire Group, which received its most recent investment in May 2025. The firm has recorded two portfolio exits: ActivePipe in February 2022 and AIRE. PieLAB subsequently broadened its remit through the PieLAB Council Capital Fund, structured as a serial acquirer that permanently holds and grows private businesses, reflecting a buy-grow-and-hold philosophy rather than a traditional exit-driven VC model. PieLAB's core edge is its backing from Australian real estate's most established agency brands, which gives portfolio companies direct commercial pathways into the country's fragmented but large residential property market. For founders building technology for real estate professionals, this combination of venture capital and industry-insider distribution is a material advantage over a purely financial investor.

Pier 70 Ventures is a venture capital firm based in Seattle, launched in 2020 by former Boeing executives with a focus on healthcare and med-tech innovation. The firm operates with a mission to fund impact-driven companies, especially those leveraging AI, data, and cloud technologies to reshape healthcare. Pier 70 is particularly known for supporting diverse leadership teams and sees diversity as a key driver for financial returns. Their areas of interest include digital health, diagnostics, and med-tech. The founding team, which includes industry veterans like R. Miller Adams, Shaun Hawkins, and Bob Balk, brings deep expertise from both the corporate and investment worlds. For example, Adams and Balk developed Boeing’s venture capital arm, growing it into a $250 million fund-of-funds. At Pier 70, they aim to replicate this success by connecting startups with a global network of healthcare leaders, corporate investors, and biopharma companies. Pier 70's initial fund, the INpact Fund, focuses on early-stage to Series B investments, with check sizes ranging from $250,000 to $2 million. The firm is committed to fostering innovation and reducing economic inequality by backing underrepresented entrepreneurs. They’ve already made notable investments in startups like DocSpera, a surgical coordination platform, and Acclinate, a company focused on increasing diversity in clinical trials. Pier 70 aims to fund up to 22 companies with its first fund, contributing not just capital but strategic guidance to help startups scale and thrive.

Pillar VC is a venture capital firm based in Boston, Massachusetts, specializing in early-stage investments, particularly in pre-seed and seed rounds. Founded in 2016, the firm focuses on supporting founders from the very beginning, often before formal incorporation, and invests in various sectors including AI/ML, biotech, consumer, enterprise, fintech, and crypto/web3. Pillar VC manages multiple funds, including the recent $192 million raised for Pillar III and Pillar Select. This allows them to continue backing companies with significant potential to become foundational pillars of their industries. Their investment strategy includes leading seed rounds with investments ranging from $2 million to $6 million and making pre-seed investments between $50,000 and $500,000. The firm is distinguished by its commitment to buying common stock to align closely with the founders' interests. Pillar VC also provides robust support through a dedicated platform team that assists with talent acquisition, expert connections, pitch polishing, and investor introductions. This approach has helped foster successful companies like Algorand, Desktop Metal, and PillPack​.

Pilot House Ventures is a Boston, Massachusetts-based early-stage venture capital firm founded in 2001 and headquartered at The Pilot House, Lewis Wharf. The firm historically focused on promising early-stage technology companies in enterprise software, network infrastructure, internet, and communications. Managing Director Benjamin A. Gomez and Partner Eric P. Krauss led the three-person team. Pilot House typically entered at the Series A financing stage with initial checks of $2 million to $4 million, giving preference to New England-based companies it could support in person. The firm managed four funds, including Pilot House Ventures II LP. Across its history, Pilot House made 72 investments and delivered one IPO and 12 acquisitions. Notable exits include Stoke, BigBand Networks, and Mazu Networks. The firm built a strong regional reputation as an active Series A partner for Boston-area enterprise technology and networking startups. The most recent tracked portfolio exit was Qualtre in January 2016, and the firm's most recent disclosed new investments date to 2021, indicating that Pilot House is effectively inactive and no longer deploying capital into new deals. Pilot House Ventures played a meaningful role in the Boston technology ecosystem during the early 2000s and 2010s, providing regionally focused, hands-on venture support to enterprise software and communications companies at a time when New England VC was less crowded than today. Its operational history of 72 investments and more than 30 total exits reflects a consistent strategy of backing capital-efficient enterprise technology companies with clear paths to acquisition by larger platform vendors.

Ping An Ventures is the corporate venture capital arm of Ping An Insurance (Group) Company of China, one of China's largest insurance and financial services conglomerates. Founded in 2012 with RMB 1 billion (~$150 million) of seed capital from Ping An Insurance, the firm is headquartered in Pudong, Shanghai and holds the distinction of being the first VC fund launched out of China's financial industry. Ping An Ventures invests across fintech, healthcare, consumer, and technology verticals — spanning domestic and overseas opportunities — with a focus on middle-to-late growth rounds, pre-IPO, and PIPE transactions that align with Ping An's own digital transformation roadmap. The firm has made approximately 160 investments across its history, with check sizes typically ranging from $3 million to $50 million. To extend its global reach, Ping An Ventures launched the Hong Kong-based Global Voyager fund at $1 billion to source healthcare and fintech assets in the United States, Israel, and Singapore, and has targeted up to $1.3 billion across two additional healthcare-focused growth-stage funds. Notable portfolio companies include Didi Chuxing, Meituan-Dianping, Oscar Health, Payoneer, Taulia, Hycor Biomedical, Fabric Genomics, and Tmunity Therapeutics. Recent exits include eToro and Fabric Genomics, acquired by GeneDx for $51 million in April 2025. Ping An Ventures operates with a lean team of eight investment professionals and maintains a disciplined approach to portfolio construction, concentrating on companies where Ping An's insurance, fintech, and healthcare networks create tangible strategic advantage. The firm functions as both a financial investor and a strategic partner, connecting portfolio companies to Ping An's vast distribution ecosystem across China and select global markets.

Pink Salt Ventures, founded in 2019, is the UK's first venture capital firm dedicated exclusively to investing in female-led startups. Headquartered in London, the firm focuses on early-stage investments, particularly in the technology, wellness, and femtech sectors. Pink Salt Ventures partners with female entrepreneurs building innovative solutions across health, sextech, and wellness, with investment sizes typically ranging from €100,000 to €1.5 million. Founded by Samira Qassim and Saloni Bhojwani, Pink Salt Ventures aims to address the significant funding gap faced by female founders in Europe. Their approach goes beyond just providing capital; they emphasize mentorship, strategic guidance, and long-term partnership to help entrepreneurs build impactful, lasting businesses. The firm’s ethos is centered on backing founders who display grit, resilience, and an unstoppable drive to succeed. Pink Salt Ventures has already supported a number of promising startups, including MPowder, a menopause-focused health brand, Juno Bio, which decodes the vaginal microbiome, and Mirza, a platform aimed at bridging the financial gap in childcare. The firm’s impact-focused strategy seeks to elevate female founders, who have historically been underrepresented in venture capital, while delivering strong returns​.

Pinnacle Ventures is a Burlingame, California-based investment firm founded in 2002 that specializes in providing both venture debt and venture equity financing to high-growth companies across the United States. Led by principals Kenneth R. Pelowski and Robert N. Savoie, the firm operates as investment manager and adviser to a family of venture debt and equity funds — including Pinnacle Ventures Debt Fund III, whose limited partners include The Prudential Insurance Company of America. While sector-agnostic, Pinnacle concentrates its activity in clean technology, healthcare, and information technology, with particular emphasis on internet, mobile, media, enterprise, and software companies. Pinnacle writes venture-debt checks from $500,000 up to $25 million and venture-equity checks up to $15 million, offering founders flexible growth-capital solutions that complement equity rounds without undue dilution. Across 177 investments in 137 unique portfolio companies, the firm has produced 2 unicorns and 98 exits — a strong track record for a venture-debt-led platform. Notable portfolio companies include One Medical, Bonobos, and Kabam. The firm's most recent disclosed investment was a $50 million Series C round in VOOX in January 2025, and its most recent exit was Lotame, acquired by Publicis Groupe in March 2025. Pinnacle's dual debt-plus-equity model is central to its value proposition: by combining venture loans with equity participations, the firm can tailor capital structures to each company's growth trajectory and founder preferences. This flexibility positions Pinnacle as a complement to traditional equity-only VCs and allows founders to preserve dilution while accessing growth runway. The firm's long operating history since 2002 gives it a broad perspective across market cycles.

Pinto Ventures AG is a Swiss seed-stage venture capital and company-building firm founded in 2019 and headquartered in Walchwil in the canton of Zug. The firm is structured as a single-LP fund and is led by Founder Joao Monteiro, formerly VP of New Business at global logistics giant Kuehne + Nagel. Pinto focuses on angel and pre-seed to seed investments in founders building across fintech, logistics technology, healthtech, and retail, with a deliberate geographic concentration on Europe. Check sizes range from approximately $250,000 to $5 million. Pinto Ventures has made roughly 15 investments over its history, and two portfolio companies have been acquired: Monese, a UK challenger bank, and VONZU, a SaaS delivery-management platform. Other notable portfolio investments include eTEU (maritime and logistics software), Roundabout (marketplace), and XYB (financial software). Co-investors across Pinto's deals include Kinnevik, PayPal, Speedinvest, Global Founders Capital, HSBC, Investec, Cavalry Ventures, and Axa Venture Partners — demonstrating strong alignment with top-tier European and global VCs. Pinto positions itself as a capital-plus-craft investor: bringing time, capital, and access together in equal measure. The firm offers hands-on collaborative support to founders via impactful introductions across key business areas and operates with what it calls 'skin in the game' — its own principals are actively engaged in the commercial development of each portfolio company rather than serving purely in a board-oversight capacity. The team of two partners keeps the portfolio concentrated and ensures close attention to each founder relationship.

Pioneer Fund, founded in 2018, is a venture capital firm driven by over 400 Y Combinator alumni, targeting early-stage investments in startups emerging from the Y Combinator accelerator. The fund focuses primarily on seed rounds and is industry-agnostic, backing companies across sectors like AI, fintech, life sciences, and consumer products. Notably, Pioneer Fund has supported the rise of Anthropic, an AI startup that became a unicorn in 2023. Geographically, Pioneer Fund predominantly invests in the US, but has also expanded its portfolio with startups from India, Nigeria, and several other countries. The firm tends to co-invest with other prominent players, often alongside Y Combinator itself, as well as other top-tier VCs. Their strategy revolves around writing early checks and providing more than just capital—leveraging the collective expertise of their vast alumni network to offer founders mentorship, connections, and operational insights. Pioneer Fund typically doesn't lead rounds but is quick to follow other strong investors within the YC ecosystem. The fund is managed by a large team of partners and venture partners based in locations like San Francisco, Toronto, and Vancouver. If you’re a YC startup with a strong product-market fit and a clear path to growth, Pioneer Fund might be a key player in your next funding round, especially if you seek connections within the YC network.

Pioneer Fund, founded in 2017, is a venture capital firm based in San Francisco, CA, and Toronto, Canada. This unique fund is driven by over 400 Y Combinator alumni, focusing on investing in top startups that emerge from the Y Combinator accelerator. With a strong emphasis on early-stage investments, Pioneer Fund supports a diverse range of industries, including consumer products, financial services, AI, life sciences, and education technology. Notable investments by Pioneer Fund include companies like Aspire, C16 Biosciences, Curebase, Dover, and OnDeck, reflecting their broad and impactful portfolio. The fund has made over 600 investments and continues to actively support new ventures, emphasizing their commitment to fostering innovation and growth in the startup ecosystem. Pioneer Fund operates with a flexible and founder-friendly approach, often providing quick investment decisions. They also maintain a global investment perspective, with a presence in countries such as India, Nigeria, Argentina, and Chile. This geographical diversity enables them to back startups with international ambitions and scalability. The team at Pioneer Fund is led by founder Daniel Gross, along with other notable members such as Tim Suzman and Rajiv Bhat. They bring a wealth of experience and connections, leveraging their backgrounds as Y Combinator alumni to provide valuable mentorship and support to portfolio companies.

Pioneers Ventures is a pre-seed investment fund established in 2015 as part of a collaboration between Pioneers and Speedinvest. The fund focuses on investing in early-stage startups across various sectors, including Business Tech, Consumer Tech, Fintech, and Health Tech. Following a restructuring, Pioneers Ventures continues to operate under the startup300 umbrella, which offers a broad range of services including financial support, networking, and corporate collaboration opportunities. Pioneers Ventures stands out by not only providing capital but also offering extensive support through business scaling consulting, access to a global network of corporate and public sector partners, and guaranteed publicity. They also provide co-founding opportunities and consulting in business model development, aiming to help startups grow from the ground up. The firm has a diverse portfolio of investments that include innovative companies such as Blockpit (cryptocurrency compliance), Fretello (AI-based guitar learning), and Mooci (a digital network for aesthetic medicine). Additionally, Pioneers offers a "Venture Clienting" service, which helps corporations collaborate with startups to innovate and develop new solutions​.

Pipeline Angels is a unique investing network that focuses on empowering women and non-binary individuals to become investors and support underrepresented founders. Founded in 2011, the organization has built a community that redefines who gets to be an investor and what kinds of ventures receive funding. Their mission is to create capital opportunities for trans women, cis women, non-binary, two-spirit, and gender-nonconforming founders who are often overlooked by traditional funding sources. Pipeline Angels has invested over $8 million in more than 120 for-profit social ventures through their signature Pitch Summit process. This process allows startups to pitch directly to investors, helping bridge the gap for founders who typically lack access to capital. The network emphasizes impact investing, backing startups that aim to create social and environmental change alongside financial returns. Members of Pipeline Angels participate in investing bootcamp that offers education, mentoring, and practice in early-stage investing. The network's focus on diversity and impact has helped reshape the landscape of venture capital by increasing funding for underrepresented founders and encouraging more women and non-binary individuals to step into the role of investor.